FierceBiotech

EMD Serono’s Commitment to Advance Multiple Sclerosis Care and Research Underscored by Data to Be Presented at AAN 2011 Me

ROCKLAND, Mass.--(BUSINESS WIRE)-- EMD Serono, Inc., an affiliate of Merck KGaA, Darmstadt, Germany, today announced that new data from the company’s multiple sclerosis (MS) portfolio will be ...
FiercePharma

Teva to Present Multiple Sclerosis Data at 67th American Academy of Neurology (AAN) Annual Meeting in Washington, D.C.

Study design detailed for ARPEGGIO, Phase II evaluation of laquinimod in primary-progressive multiple sclerosis (PPMS) JERUSALEM--(BUSINESS WIRE)--Apr. 13, 2015-- Teva Pharmaceutical Industries Ltd., ...
Seeking Alpha

Helius Medical Announces Poster to Be Presented at the Consortium for Multiple Sclerosis Centers (CMSC) Annual Conference

NEWTOWN, Pa., May 31, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that an ...
Nasdaq

Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and ...

Celgene Corporation (NASDAQ:CELG) today announced it will present 13 scientific abstracts, including new analyses from the Phase 3 ozanimod clinical development program in adults with relapsing forms ...